Loading...
Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim–Chester disease
Abstract Background Erdheim–Chester disease (ECD) is a rare multi-systemic form of histiocytosis. Treatment with BRAF inhibitors has markedly improved outcomes of ECD; however, this targeted therapy is expensive (estimated annual cost is $50,000). Since estimated annual cost of interferon-α (IFN-α)...
Na minha lista:
Main Authors: | , , , , , , , , |
---|---|
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
BMC
2019-01-01
|
Serier: | Orphanet Journal of Rare Diseases |
Fag: | |
Online adgang: | http://link.springer.com/article/10.1186/s13023-018-0988-y |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|